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Edited by Robert BaroukiAbstract 4-Methyl-N1-(3-phenyl-propyl)-benzene-1,2-diamine
(JSH-23) is a novel chemically synthetic compound. The
aromatic diamine JSH-23 compound exhibited inhibitory eﬀect
with an IC50 value of 7.1 lM on nuclear factor (NF)-jB
transcriptional activity in lipopolysaccharide (LPS)-stimulated
macrophages RAW 264.7, and interfered LPS-induced nuclear
translocation of NF-jB without aﬀecting IjB degradation. This
mechanism of action is very rare for controlling NF-jB activa-
tion. Furthermore, the compound inhibited not only LPS-induced
expressions of tumor necrosis factor-a, interleukin (IL)-1b, IL-6
and inducible nitric oxide synthase and cyclooxygenase-2 but also
LPS-induced apoptosis of the RAW 264.7 cells.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Nuclear factor (NF)-jB is a transcription factor with hete-
rodimer or homodimer form of rel family proteins such as
RelA (p65), RelB, cRel, p50 and p52 [1]. NF-jB is sequestered
in the cytoplasm, bound to inhibitory jB (IjB) proteins such
as IjBa, IjBb, IjBe, p105 and p100 [2]. Lipopolysaccharide
(LPS), a major component of the outer membranes of Gram-
negative bacteria, can trigger a variety of inﬂammatory reac-
tions by binding to Toll-like receptor 4 [3,4]. Downstream
signaling components of the receptor include MyD88, inter-
leukin (IL)-1 receptor-associated kinase, and tumor necrosis
factor (TNF) receptor-associated factor 6, which activates IjB
kinase (IKK) complex [5,6]. Activation of IKK complex re-
sults in phosphorylation of IjB, which marks for ubiquitina-
tion followed by proteasome-mediated degradation [7]. IjB
degradation unmasks the nuclear localization signal (NLS) of
NF-jB, allowing the transcription factor to translocate to the
nucleus, and then NF-jB binds to the promoter region of
immune and inﬂammatory genes for transcriptional regulation
[8,9].* Corresponding author. Fax: +82-43-268-2732.
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doi:10.1016/j.febslet.2004.06.056In the present study, novel aromatic diamine 4-Methyl-N 1-
(3-phenyl-propyl)-benzene-1,2-diamine (JSH-23) compound
(Fig. 1) was discovered to inhibit NF-jB transcriptional ac-
tivity in LPS-stimulated macrophages RAW 264.7. The com-
pound inhibited nuclear translocation of NF-jB p65 without
aﬀecting IjBa degradation, which is a very rare mode of ac-
tion. Furthermore, JSH-23 compound caused down-regulation
of LPS-inducible cytokines and enzymes, and inhibited LPS-
induced apoptosis of the RAW 264.7 cells.2. Materials and methods
2.1. Materials
LPS (E. coli 055:B5) was purchased from Sigma–Aldrich and fetal
bovine serum (FBS) from Invitrogen. Antibodies against NF-jB p65
or IjBa were obtained from Santa Cruz Biotech. Chemical prepara-
tion of JSH-23 compound (purity, P 98%) was described elsewhere
[10].
2.2. Cell culture
Macrophages RAW 264.7 were cultured in DMEM (10 mg/ml
Dulbecco’s modiﬁed Eagle’s medium, 10 mM HEPES, 24 mM
NaHCO3, 143 U/ml benzylpenicillin potassium, and 100 lg/ml strep-
tomycin sulfate, pH 7.1) containing 10% FBS at 37 C with 5% CO2.
The RAW 264.7 cells harboring pNF-jB-secretary alkaline phospha-
tase (SEAP)-NPT reporter construct [11] were grown in the same
conditions except supplement of 0.5 mg/ml geneticin to the media.
2.3. Measurement of NF-jB transcriptional activity
Macrophages RAW 264.7 transfected stably with reporter plasmid
of pNF-jB-SEAP-NPT were treated with 1 lg/ml LPS and/or sample
for 16 h. As the reporter, SEAP activity in the cell-free culture media
was measured as described in our previous work [11].
2.4. Electrophoretic mobility shift assay of NF-jB
Macrophages RAW 264.7 were treated with 1 lg/ml LPS plus
sample for 1 h. The 32P-labeled oligonucleotide containing jB se-
quence (Promega) was reacted with nuclear extracts (10 lg) of the
RAW 264.7 cells and then resolved on non-denaturing 6% polyacryl-
amide gel by electrophoresis. The gel was dried and exposed to X-ray
ﬁlm.
2.5. Western immunoblot of NF-jB or IjB
Macrophages RAW 264.7 were treated with 1 lg/ml LPS and/or
sample for 1 h (NF-jB) or for 10 min-8 h (IjB). Western immunoblot
for NF-jB p65 was carried out with nuclear extracts and that of IjBa
with cytoplasmic extracts. Western immunoblot conditions were de-
scribed in our previous work [12]. The blots were ﬁnally reacted withblished by Elsevier B.V. All rights reserved.
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Fig. 1. Chemical structure of aromatic diamine JSH-23 compound.
1 3 10 30 100 300
W
ST
-1
 (c
on
tro
l %
)
0
25
50
75
100
*
H.-M. Shin et al. / FEBS Letters 571 (2004) 50–54 51ECL detection reagents (Amersham-Pharmacia) and exposed to X-ray
ﬁlm.
2.6. Semi-quantitative RT-PCR
Macrophages RAW 264.7 were treated with 1 lg/ml LPS and/or
sample for 6 h. Total RNA was puriﬁed from the cells using a Fast-
RNA Kit (Bioneer) and then subjected to semi-quantitative RT-PCR
using an RNA PCR Kit (Bioneer). Primer sequences and RT-PCR
conditions were described in our previous work [12]. RT-PCR prod-
ucts were resolved on 1.5% agarose gel by electrophoresis and then
stained with ethidium bromide.
2.7. Measurement of apoptosis
Apoptosis was analyzed by 40,6-diamidino-2-phenylindole (DAPI)
staining [13]. Macrophages RAW 264.7 were treated with 1 lg/ml LPS
and/or sample for 24 h. The cells were stained with 1 lg/ml DAPI for
30 min at 37 C and then analyzed using ﬂuorescence microscopy with
excitation at 300–500 nm. Cells with nuclei containing clearly con-
densed chromatin or cells with fragmented nuclei were scored as an
apoptosis index.
2.8. Cytotoxicity measurement
Macrophages RAW 264.7 were incubated with various concentra-
tions of JSH-23 compound for 24 h. The cells were treated with WST-1
solution as described in our previous work [14] and absorbance was
measured at 450 nm.
2.9. Statistical analysis
Resulting values were otherwise expressed as means S.E.M. Data
were analyzed by ANOVA followed by the Student’s t test. P < 0:01
was considered signiﬁcant.JSH-23 (µM)
Fig. 3. Cytotoxic eﬀect of JSH-23 compound. Macrophages RAW
264.7 were treated with various concentrations of JSH-23 compound
for 24 h. Proliferation of the cells was analyzed with WST-1 method,
and is represented as control %, compared with that of media alone-
treated group. Data are meansS.E.M. ðn ¼ 5Þ. P < 0:01 vs. media
alone-treated group.3. Results
3.1. Inhibitory eﬀect on NF-jB transcriptional activity
NF-jB transcriptional activity was monitored using mac-
rophages RAW 264.7 transfected stably with a reporter plas-SE
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Fig. 2. NF-jB mediated reporter gene expression. Macrophages RAW 264.7
LPS and/or JSH-23 compound for 16 h. As the reporter, SEAP expression is
(left panel). Eﬀects of JSH-23 compound (solid circle) or parthenolide (open
inhibition % (right panel). Data are means S.E.M. ðn ¼ 3Þ. #P < 0:01 vs. mmid containing four copies of the jB sequence and SEAP as
the reporter. Treatment of LPS to the transfected RAW 264.7
cells increased SEAP expression to about 3-fold, compared
with the resting cells, indicating that cellular NF-jB is trans-
criptionally functional (Fig. 2). JSH-23 compound inhibited
LPS-induced SEAP expression in a dose-dependent manner,
corresponding to 23 3% inhibition at 3 lM, 68 3% at 10
lM and 103 4% at 30 lM (Fig. 2). Parthenolide, an inhibitor
of IKK complex on NF-jB activation [15], also exhibited an
IC50 value of 3.5 lM on LPS-induced SEAP expression.
However, JSH-23 alone did not cause the SEAP expression
(Fig. 2). The inhibitory eﬀect of JSH-23 compound on LPS-
induced reporter expression was not attributable to its cyto-
toxicity, because the compound at <100 lM did not show
signiﬁcant cytotoxic eﬀects on the RAW 264.7 cells (Fig. 3).
3.2. Inhibitory eﬀect on DNA binding activity of NF-jB
To elucidate the mechanism, we next determined whether
JSH-23 compound could inhibit DNA binding activity of NF-
jB in LPS-stimulated macrophages RAW 264.7. Treatment ofSample (µM)
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edia alone-treated group. P < 0:01 vs. LPS alone-treated group.
Fig. 5. Western immunoblot of NF-jB p65. Macrophages RAW 264.7
were treated with LPS and/or JSH-23 compound for 1 h, and nuclear
extracts were subjected to Western immunoblot with anti-NF-jB p65
antibody. One of the similar immunoblot results is represented and
relative ratio % is also shown, compared with LPS alone-treated group
(100 5%). Data are means S.E.M. ðn ¼ 3Þ. #P < 0:01 vs. media
alone-treated group. P < 0:01 vs. LPS alone-treated group.
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activity of NF-jB complex within 1 h (Fig. 4). Under the same
conditions, JSH-23 compound decreased LPS-induced DNA
binding activity of NF-jB in a dose-dependent manner
(Fig. 4).
3.3. Inhibitory eﬀect on nuclear translocation of NF-jB
To further investigate whether JSH-23 compound could af-
fect nuclear translocation of NF-jB, Western immunoblot for
NF-jB p65 was carried out with nuclear extracts of LPS-
stimulated RAW264.7 cells. Nuclear amount of NF-jB p65
was markedly increased upon exposure to LPS for 1 h (Fig. 5).
Treatment of JSH-23 compound to LPS-stimulated RAW
264.7 cells decreased nuclear content of NF-jB p65 in a dose-
dependent manner, corresponding to 49 4% inhibition at 3
lM, 75 7% at 10 lM and 95 8% at 30 lM (Fig. 5).
3.4. Eﬀect on IjB degradation
Another immunoblot was carried out with cytoplasmic ex-
tracts of LPS-stimulated macrophages RAW 264.7 to know
whether IjB degradation was inﬂuenced by JSH-23 com-
pound. IjBa degradation was dramatically happened within
10 min upon exposure to LPS and JSH-23 compound (30 lM)
did not inhibit LPS-induced IjBa degradation (Fig. 6). Cyto-
plasmic content of IjBa was recovered to basal level at 40–50
min after LPS-induced IjBa degradation, which was not in-
hibited or delayed until 8 h by treatment of JSH-23 compound
(Fig. 6).
3.5. Inhibitory eﬀect on expressions of pro-inﬂammatory
cytokines and enzymes
JSH-23 compound inhibited LPS-induced NF-jB activa-
tion, and thus eﬀect of the compound on expressions of
LPS-inducible cytokines and enzymes was analyzed by semi-Fig. 4. EMSA of NF-jB complex. Macrophages RAW 264.7 were
treated with LPS and/or JSH-23 compound for 1 h, and nuclear ex-
tracts were subjected to DNA binding activity with 32P-labeled oli-
gonucleotide speciﬁc to NF-jB. Speciﬁc DNA binding of NF-jB
complex is indicated by an arrow.quantitative RT-PCR. As shown in Fig. 7, expressions of IL-
1b, IL-6, inducible nitric oxide synthase (iNOS) and cycloox-
ygenase (COX)-2 transcripts, except that of TNF-a transcript,
were hardly detectable in the resting RAW 264.7 cells. How-
ever, the cells expressed pronounced amounts of the pro-in-
ﬂammatory transcripts when stimulated with LPS for 6 h.
JSH-23 compound showed diﬀerential inhibitory eﬀects on
LPS-induced expressions of the pro-inﬂammatory transcripts;
IL-6 and iNOS at P 3 lM, IL-1b and COX-2 at P 10 lM and
TNF-a at P 30 lM (Fig. 7).
3.6. Inhibitory eﬀect on apoptosis
Apoptosis was evaluated by DAPI staining. Apoptotic nu-
clei with condensed chromatin were detectable in macrophages
RAW 264.7 by stimulation of LPS for 24 h but not by treat-
ment of JSH-23 alone (Fig. 8). JSH-23 compound inhibited
LPS-induced chromatin condensation in a dose-dependentFig. 6. Western immunoblot of IjBa. Macrophages RAW 264.7 were
treated with LPS and/or JSH-23 compound (30 lM) for the indicated
times, and cytoplasmic extracts were subjected to Western immunoblot
with anti-IjBa antibody.
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Fig. 8. Eﬀect on LPS-induced apoptosis. Macrophages RAW 264.7
were treated with LPS and/or JSH-23 compound for 24 h, and stained
with DAPI. Apoptotic score is represented as relative ratio %, com-
pared with LPS alone-treated group. Data are meansS.E.M.
ðn ¼ 4Þ. #P < 0:01 vs. media alone-treated group. P < 0:01 vs. LPS
alone-treated group.
Fig. 7. RT-PCR of pro-inﬂammatoty cytokines (TNF-a, IL-1b and IL-
6) and enzymes (iNOS and COX-2). Macrophages RAW 264.7 were
treated with LPS and/or JSH-23 compound for 6 h, and total RNA
was subjected to semi-quantitative RT-PCR using b-actin as the in-
ternal control.
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at 10 lM and 93 3% at 30 lM (Fig. 8).4. Discussion
In the present study, novel aromatic diamine JSH-23
compound was discovered to have inhibitory eﬀect on NF-
jB transcriptional activity in LPS-stimulated macrophages
RAW 264.7 (Fig. 2). To clarify the mechanism by which
JSH-23 compound inhibited NF-jB activation, electropho-
retic mobility shift assay (EMSA) and Western immunoblot
were carried out. JSH-23 compound showed inhibitory ef-
fects, in parallel, on LPS-induced DNA binding activity andnuclear translocation of NF-jB p65 (Figs. 4 and 5). How-
ever, JSH-23 compound did not inﬂuence LPS-induced IjBa
degradation and did not inhibit or delay cytoplasmic IjBa
recovery until 8 h after LPS-induced IjBa degradation
(Fig. 6). These results indicate that JSH-23 compound could
inhibit LPS-induced nuclear translocation of NF-jB p65
without aﬀecting IjBa degradation. In most mammalian
cells, IjBa is rapidly degraded (<10 min) following phos-
phorylation but is quickly resynthesized (50–60 min) in an
NF-jB-dependent manner [16]. Newly synthesized IjBa
binds with nuclear NF-jB for an autoregulatory pathway to
ensure the proper balance of NF-jB and IjBa in the cell [2].
Three NF-jB binding sites are reported in the IjBa pro-
moter, where one site binds only NF-jB p50 complexed with
itself, p65 or cRel and the other sites bind NF-jB complexes
predominantly comprised of p65 and cRel homodimers or
heterodimers [17]. We demonstrated that LPS-induced nu-
clear translocation of NF-jB p65 was dose-dependently in-
hibited by JSH-23 compound (Fig. 5). However, NF-jB
complexes comprised p50, cRel or others which can induce
IjBa transcription by themselves. Thus, JSH-23 compound
presumably has diﬀerential eﬀects on nuclear translocation
of other members of NF-jB family.
Synthetic peptide SN50, containing a hydrophobic mem-
brane-translocating region and the NLS of NF-jB p50, was
reported to inhibit nuclear translocation of NF-jB in response
to LPS and TNF-a [18]. In LPS-stimulated cells, various en-
zymes are activated, leading to the phosphorylation and sub-
sequent degradation of IjB, freeing NF-jB to be recognized
by karyopherin a [19]. Upon binding of karyopherin a to NF-
jB, they interact with karyopherin b and small GTP binding
protein, Ran [20]. These complexes bind to the nuclear pore
and then NF-jB is transported to the nucleus. Target of syn-
thetic peptide SN50 is the NLS on NF-jB p50 that is recog-
nized by karyopherin a [18]. Even though molecular target of
JSH-23 compound would be elucidated, this study is the ﬁrst
observation to show that a non-peptide compound speciﬁcally
interfered LPS-induced nuclear translocation of NF-jB with-
out aﬀecting IjB degradation as shown in synthetic peptide
SN50.
Importantly, JSH-23 compound suppressed LPS-induced
expressions of pro-inﬂammatory cytokines (TNF-a, IL-1b and
IL-6) and enzymes (iNOS and COX-2) (Fig. 7). Physiological
actions of the cytokines, iNOS and COX-2 may provide a
beneﬁt to the organism. However, aberrant or excessive ex-
pressions of the proteins have been implicated in inﬂamma-
tion-related disorders including arthritis, cancer, as well as
septic shock [21]. Furthermore, JSH-23 compound inhibited
LPS-induced apoptotic chromatin condensation (Fig. 8).
However, JSH-23 alone did not induce apoptotic death of
macrophages RAW 264.7.Acknowledgements: This work was ﬁnancially supported by grant (02-
PJ2-PG3-21605-0004) from Korea Ministry of Health and Welfare and
grant RRC (RCBH) from KOSEF.References
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